Immatics (IMTX) Debt Ratio (2020 - 2022)

Immatics' (IMTX) quarterly Debt Ratio came in at 0.06 in Q3 2022, down 57.27% year-on-year from 0.13 in Q3 2021, and up 47.15% quarter-over-quarter from 0.04 in Q2 2022.

Immatics (IMTX) Debt Ratio (2020 - 2022) Analysis & Trends

Immatics has disclosed Debt Ratio across 3 years of filings, most recently posting 0.06 for Q3 2022.

  • Debt Ratio for Q3 2022 came in at 0.06, down 57.27% year-over-year; the trailing twelve-month figure through Sep 2022 was 0.06 (down 57.27% YoY), and the FY2021 annual result was 0.16, up 140.8% from the prior year.
  • Debt Ratio came in at 0.06 for Q3 2022 at Immatics, up from 0.04 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.16 in Q4 2021 to a low of 0.04 in Q2 2022.
  • The 3-year median for Debt Ratio is 0.07 (2020), against an average of 0.08.
  • Across the five-year window, Debt Ratio soared 140.8% in 2021 and plunged 60.11% in 2022, its largest moves.
  • Immatics' Debt Ratio stood at 0.07 in 2020, then jumped by 140.8% to 0.16 in 2021, then tumbled by 64.64% to 0.06 in 2022.
  • The last three Debt Ratio figures came in at 0.06 (Q3 2022), 0.04 (Q2 2022), and 0.04 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immatics 14.67 Bn 14.67 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 0.06
Jun 30, 2022 0.04
Mar 31, 2022 0.04
Dec 31, 2021 0.16
Sep 30, 2021 0.13
Jun 30, 2021 0.10
Mar 31, 2021 0.08
Dec 31, 2020 0.07